Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Sesame Care vs Trimrose

By GLP-1 ScorecardUpdated

Sesame Care
Site position #2

Higher grade

Trimrose
Site position #490

Lower grade

Score comparison

Sesame Care has the higher recorded score — 87.8/100 to 55.4/100.

Sesame Care grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Choose a provider for Wegovy, Zepbound and oral GLP-1 options through Sesame; care and medication are billed separately, and the annual care headline needs comparison with the shorter plan.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueSesame Care +44
84
40
Dose & formulationSesame Care +28
92
64
Clinical oversightSesame Care +26
94
68
Labs & monitoringSesame Care +32
84
52
FulfillmentSesame Care +23
80
57
Contract termsSesame Care +37
92
55
Sesame Care · top barTrimrose · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricSesame CareTrimrose
WeighScore87.8/10055.4/100
GradeB+C
Site position#2#490
SemaglutideBrand Wegovy pill from $149/mo at 1.5/4 mg; $299 at 9/25 mg, plus required care: from $59/mo on annual subscription or $99 every 28 days (confirm billing)Not disclosed
TirzepatideBrand Zepbound vials from $299/mo at 2.5 mg; higher doses cost more and KwikPen pages conflict, plus required care (confirm selected product and billing)Not disclosed
CoverageU.S. marketplace; provider and treatment availability varies; confirm your stateCoverage not published
Brand-name accessYesYes
Oral / sublingualYesYes
Sesame Care

Site position #2 · B+

Strengths

  • Provider choice with advertised video visits, follow-ups and continuing messaging
  • Branded injection and oral options are described, subject to prescribing, dose, insurance and pharmacy availability
  • Quest lab costs are included except in nine named states; alternative lab coverage requires confirmation
  • The current semaglutide page explicitly distinguishes branded products from compounded semaglutide, which it says is currently unavailable

What to consider

  • The $59 care headline requires an annual subscription and excludes medication; provider-specific care rates may be higher
  • Ordinary care is called monthly but also billed every 28 days; longer-term savings arithmetic needs confirmation
  • Program refund wording differs from newer terms describing multi-month repricing and a 48-hour renewal notice
  • Drug prices depend on dose and promotion; official KwikPen and Foundayo displays contain discrepancies
  • The selected clinician, medical practice and dispensing pharmacy were not established by this review
Trimrose

Site position #490 · C

Strengths

  • Free, no-cost, no-obligation online eligibility quiz before any commitment
  • Offers a choice of a weekly compounded GLP-1 injection or a daily oral option
  • Fully online — assessment, provider review, and home delivery with ongoing support

What to consider

  • Runs on the CareValidate white-label platform and isn't the medical provider itself — a support@carevalidate.com address is exposed on the site
  • Pricing isn't shown publicly; the cost and the specific compounded molecule appear only after you complete the eligibility quiz
  • The states served, pharmacy partner and any LegitScript/503A certification aren't disclosed on the public site
  • Markets 'up to 22.5% of body weight' — a trial figure for branded tirzepatide, not a guaranteed or compounded-specific outcome
  • Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name

Featured provider

Sesame Care

Sesame Care scores 87.8/100 (B+). Choose a provider for Wegovy, Zepbound and oral GLP-1 options through Sesame; care and medication are billed separately, and the annual care headline needs comparison with the shorter plan.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard